Table 1 Demographic and clinical characteristics of the study population
Demographic characteristics/Risk factors | Patient group (n = 19) | Control group (n = 19) |
|---|---|---|
Age, years (mean ± SD) | 47.8 ± 17.4 | 47.8 ± 17.6 |
Max | 22 | 22 |
Min | 71 | 73 |
≤ 52 years | ||
Number of Subjects (%) | 11 (57.9) | 11 (57.9) |
≥ 53 years | ||
Number of Subjects (%) | 8 (42.1) | 8 (42.1) |
Sex | ||
Female | ||
Number of Subjects | 9 (47.4) | 9 (47.4) |
Age, years (mean ± SD) | 54 ± 17.8 | 54.3 ± 18.1 |
Max | 23 | 23 |
Min | 71 | 73 |
Male | ||
Number of Subjects | 10 (52.6) | 10 (52.6) |
Age, years (mean ± SD) | 42.3 ± 15.9 | 42 ± 15.9 |
Max | 22 | 22 |
Min | 71 | 70 |
Risk factors (%) | ||
No risk factor | 5 (26.3) | 6 (31.6) |
At least one risk factor | 14 (73.7) | 13 (68.4) |
Current smoker | 4 (21) | 4 (21) |
Smoking past | 3 (15.8) | 3 (15.8) |
Hypertension | 4 (21) | 5 (26.3) |
Hypercholesterolemia | 4 (21) | 2 (10.5) |
Hypertriglyceridemia | 2 (10.5) | 3 (15.8) |
Family history of cardiovascular and cerebrovascular disease | 5 (26.3) | 8 (42.1) |
Diabetes mellitus | 1 (5.3) | 3 (15.8) |
Overweight/Obesity | 10 (52.6) | 8 (42.1) |
Therapy (%) | ||
No therapy | 15 (79%) | 14 (73.7%) |
Antidiabetic therapy | 1 (5.2%) | 0 |
Lipid-lowering drugs | 2 (10.5%) | 1 (5.2%) |
Anti-hypertensive drugs | 4 (21%) | 5 (26.3%) |